1. |
van den Berghe G, Wouters P, Weekers F, et al. Ineensive insulin therapy in criticaiiy ill patients [J]. N Eng J Med, 2001; 345(19): 1359-1367.
|
2. |
Das UN. Insulin and Inflammation: further evidence and discussion [J]. Nutrition, 2002; 18(6): 526-527.
|
3. |
Hirsch IB. Effect of insulin therapy on nonglycemic variables during acute illness [J]. Endocr Pract, 2004; 10(Suppl 2): 63-70.
|
4. |
Jeschke MG, Einspanier R, Klein D, et al. Insulin attenuates the systemic inflammatory response to thermal trauma [J]. Mol Med, 2002; 8(8): 443-450.
|
5. |
黄志强, 董家鸿, 王敖川, 等. 胆源性脓毒症对肝脏线粒体呼吸功能的影响 [J]. 中国普外基础与临床杂志, 2000; 7(2): 66-68.
|
6. |
黄志强主编. 黄志强胆道外科 [M]. 第1版. 济南: 山东科学技术出版社, 2000: 228-230.
|
7. |
Robinson LE, van Soeren MH. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control [J]. AACN Clin Issues, 2004; 15(1): 45-62.
|
8. |
Steve W. The role of mediators in sepsis resolution. Advan-ces in sepsis [J]. 2002; 2(1): 8-14.
|
9. |
Cheung NW, Napier B, Zaccaria C, et al. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition [J]. Diabetes Care, 2005; 28(10): 2367-2371.
|
10. |
Krinsley JS. Association between hyperglycemia and increas-ed hospital mortality in a heterogeneous population of crically inn patients [J]. Mayo Clin Proc, 2003; 78(12): 1471-1478.
|
11. |
姚永明, 孟海东. 脓毒症高血糖与胰岛素强化治疗策略 [J]. 中国危重病急救医学杂志, 2006; 18(2): 68-70.
|
12. |
Hansen TK, Thiel S, Wouters PJ, et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels [J]. J Clin Endocrinol Metab, 2003; 88(3): 1082-1088.
|
13. |
Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? [J]. J Clin Invest, 2004;114(9): 1187-1195.
|
14. |
Weekrs F, Giulietti AP, Michalaki M, et al. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness[J]. Endocrinology, 2003; 144(12): 5329-5338.
|
15. |
董家鸿, 韩本立, 李昆, 等. 地塞米松改变胆源性脓毒症时宿主糖代谢反应 [J]. 普外基础与临床杂志, 1994; 1(1): 15-18.
|
16. |
孙文斌, 马瑞亮, 韩本立, 等. 大鼠胆源性脓毒症时肝脏糖异生功能及相关激素环境的改变 [J]. 中国普外基础与临床杂志, 1997; 4(3): 135-138.
|
17. |
Angus DC, Abraham E. Inrensive insulin therpy in critical illness [J]. Am J Respir Crit Care Med, 2005; 172(11): 1358-1359.
|
18. |
Finney SJ, Zekveld C, Elia A, et al. Glucose control and mortality in critically ill patients [J]. JAMA, 2003; 290(15): 2041-2047.
|
19. |
李斌, 李玉明, 李迅, 等. 环氧合酶-2对脓毒症大鼠肝损伤的影响 [J]. 中国普外基础与临床杂志, 2008; 15(4): 266-270.
|
20. |
钱建中, 潘奎. 肿瘤坏死因子在梗阻性黄疸鼠肝损伤中的作用 [J]. 腹部外科杂志, 1999; 12(5): 229-231.
|
21. |
贾士勇, 黄志强, 孟宪钧. 肿瘤坏死因子在梗阻性黄疸鼠肝中的免疫组化分析 [J]. 中华实验外科杂志, 1995; 12(4): 197-198.
|
22. |
董家鸿, 黄志强, 王傲川, 等. 实验性胆源性脓毒症时肝脏代谢反应及其调控机制的改变 [J]. 第三军医大学学报, 1994; 16(1): 4.
|
23. |
Viss R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinuses: strueture, function, and biochemistry [J]. Circ Res, 2003; 92 (8): 827-839.
|
24. |
石田孝雄, 三岛好雄. 急性化脓性胆管炎の治疗と予后, 死亡例の检讨予后决定因子にっぃこ [J]. 胆と, 1995; 16(7): 597-601.
|
25. |
De Maio A, Mooney ML, Matesic LE, et al. Genetic component in the inflammatory response induced by bacterial lipopolysaccharide [J]. Shock, 1998; 10(5): 319-323.
|